Unlocking Answers to Your Health

Sema4 is an innovative partnership of scientists, doctors, engineers, and genetic counselors dedicated to empowering healthier living through data

Our Story

Trust In Sema4

  • Our Story

    Backed by the reputation of Mount Sinai and groundbreaking research from the Icahn School of Medicine Learn More
  • Our Technology

    Six genomic technologies used in parallel to ensure comprehensive and highly accurate screening for genetic conditions Learn More
  • Our Products

    Genetic tests to empower patients and their doctors to make better health decisions, now and in the future Learn More
  • Our Research

    Breakthrough discoveries from our scientists in the fields of genetics and genomics Learn More

News

  •  
    SEMA4 PRESS RELEASE | 09.11.17

    Scientists at Sema4 and Mount Sinai Construct First Predictive Model of Inflammatory Bowel Disease

    “Scientists at the Icahn School of Medicine at Mount Sinai, Sema4, and collaborating institutions today published results of an in-depth, multi-’omics approach to characterizing the immune component of inflammatory bowel disease (IBD). These results provide new insights into the biologic networks involved in IBD with potential to identify new targets and eventually novel interventions for the treatment of patients living with IBD…”